Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010-04-14 to 2010-05-03
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
GLP guideline study reliable without restrictions
Justification for type of information:
Disodium titanate substance (EC 234-802-9) has the molecular formula Na2TiO3 and its composition is expressed as (Na2O)x(TiO2), where x is ranging from 0.1 to 6 according to the SIP. This substance, Reaction mass of Disodium Hexatitanate and Sodium Metatitanate, has a value of x = 0.21, calculated from XRF results, has been identified as a mixture of two specific types of disodium titanate and is therefore within the scope of the disodium titanate SIP.
It is assessed therefore that disodium titanate is an acceptable read-across substance for Reaction mass of Disodium Hexatitanate and Sodium Metatitanate

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010
Report date:
2010

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
, 1997
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Version / remarks:
, 2008
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
signed 2009-03-30
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium titanate
EC Number:
234-802-9
EC Name:
Disodium titanate
Cas Number:
12034-34-3
Molecular formula:
Na2TiO3
IUPAC Name:
disodium titanate
Details on test material:
- Name of test material (as cited in study report): Disodium titanate
- Physical state: light yellow powder
- Storage condition of test material: At room temperature, in tightly closed container

No further information on the test material was stated.

Method

Target gene:
the S. typhimurium histidine (his) system

- TA 1537: his C 3076; rfa-; uvrB-
- TA 98: his D 3052, rfa-, uvrB-; R-factor
- TA 1535: his G46; rfa-; uvrB-
- TA 102: his G 428; rfa-, uvrB+; R-factor
- TA 100: his G 46; rfa-, uvrB-, R-factor

The bacterial strains TA 1535, TA 1537, TA 98, TA 100, TA 102 were obtained from Trinova Biochem GmbH (35394 Gießen, Germany).
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Metabolic activation system:
S9 preparation with 34.3 mg/mL (Lot no. R 220110) in the pre-experiment/experiment I and experiment II.
Test concentrations with justification for top dose:
- experiment I: 3, 10, 33, 100, 333, 1000, 2500, and 5000 µg/plate
- experiment II: 3, 10, 33, 100, 333, 1000, 2500, and 5000 µg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: on the day of the experiment, the test item was suspended in deionised water
- Justification for choice of solvent: the solvent was chosen because of its solubility properties
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: without metabolic activation: sodium azide (TA 1535, TA100); 4-nitro-o-phenylene-diamine (TA1537, TA98); methyl methane sulfonate (TA102). With metabolic activation: 2-aminoanthracene (TA1535, TA1537, TA98, TA100, TA102)
Details on test system and experimental conditions:
METHOD OF APPLICATION:
Experiment I was performed as a plate incorporation assay. Since a negative result was obtained in this experiment, experiment II was performed as a pre-incubation assay. The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate.

Precultures:
From the thawed ampoules of the strains 0.5 mL bacterial suspension was transferred into 250 mL Erlenmeyer flasks containing 20 mL nutrient medium. A solution of 20 μL ampicillin (25 μg/mL) was added to the strains TA 98, TA 100, and TA 102. This nutrient medium contains per litre 8 g Nutrient Broth (MERCK, D-64293 Darmstadt) and 5 g NaCl (MERCK, D-64293 Darmstadt). The bacterial cultures were incubated in a shaking water bath for 4 hours at 37° C. The optical density of the bacteria was determined by absorption measurement and the obtained values indicated that the bacteria were harvested at the late exponential or early stationary phase (10E8-10E9 cells/mL).

Agar:
The plates with the minimal agar were obtained from E. Merck, D-64293 Darmstadt. The overlay agar contains per litre 6.0 g Agar Agar, 6.0 g NaCl, 10.5 mg L-Histidine x HCl x H2O and 12.2 mg Biotin (MERCK, D-64293 Darmstadt). Sterilisations were performed at 121 °C in an autoclave.

MAMMALIAN MICROSOMAL FRACTION S9 MIX
The bacteria used in this assay do not possess the enzyme systems which, in mammals, are known to convert promutagens into active DNA damaging metabolites. In order to overcome this major drawback an exogenous metabolic system is added in form of mammalian microsome enzyme activation mixture.

S9 (Preparation by Harlan CCR):
Phenobarbital/β-Naphthoflavone induced rat liver S9 is used as the metabolic activation system. The S9 is prepared from 8 - 12 weeks old male Wistar rats (Hsd Cpb: WU, Harlan Laboratories GmbH, 33178 Borchen, Germany), weight approx. 220 - 320 g induced by applications of 80 mg/kg b.w. Phenobarbital i.p. (Desitin; D-22335 Hamburg) and β-Naphthoflavone p.o. (Aldrich, D-89555 Steinheim) each on three consecutive days. The livers are prepared 24 hours after the last treatment. The S9 fractions are produced by dilution of the liver homogenate with a KCl solution (1+3) followed by centrifugation at 9000 g. Aliquots of the supernatant are frozen and stored in ampoules at -80 °C. Small numbers of the ampoules can be kept at -20 °C for up to one week. Each batch of S9 mix is routinely tested with 2-aminoanthracene as well as benzo(a)pyrene. The protein concentration in the S9 preparation was 34.3 mg/mL (lot no. R 220110) in both experiments.

S9 Mix:
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 co-factor solution. The amount of S9 supernatant was 10% v/v in the S9 mix. Cofactors are added to the S9 mix to reach the following concentrations in the S9 mix:
- 8 mM MgCl2
- 33 mM KCl
- 5 mM Glucose-6-phosphate
- 4 mM NADP
in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.

During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al. (1977).

EXPERIMENTAL PERFORMANCE:
For each strain and dose level, including the controls three plates were used. The following materials were mixed in a test tube and poured onto the selective agar plates:
- 100 μL Test solution at each dose level (solvent or reference mutagen solution (positive control)),
- 500 μL S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation),
- 100 μL Bacteria suspension (cf. test system, pre-culture of the strains),
- 2000 μL Overlay agar

In the pre-incubation assay 100 μL test solution (solvent or reference mutagen solution (positive control)), 500 μL S9 mix / S9 mix substitution buffer and 100 μL bacterial suspension were mixed in a test tube and incubated at 37 °C for 60 minutes. After pre-incubation 2.0 mL overlay agar (45 °C) was added to each tube. The mixture was poured on minimal agar plates. After solidification the plates were incubated upside down for at least 48 hours at 37 °C in the dark.

DATA RECORDING:
The colonies were counted using the Petri Viewer Mk2 (Perceptive Instruments Ltd, Suffolk CB9 7BN, UK) with the software program Ames Study Manager. The counter was connected to a PC running under Windows XP. The individual and mean values of the plates for each concentration together with standard deviations and enhancement factors as compared to the spontaneous reversion rates (see tables of results). Due to precipitation the plates were partly counted manually.
Evaluation criteria:
The Salmonella typhimurium reverse mutation assay is considered acceptable if it meets the following criteria:
- regular background growth in the negative and solvent control
- the spontaneous reversion rates in the negative and solvent control are in the range of historical data
- the positive control substances should produce a significant increase in mutant colony frequencies

A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA98, TA100, and TA102) or thrice (strains TA1535 and TA1537) the colony count of the corresponding solvent control is observed.

A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.

An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.

A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Statistics:
According to the OECD guideline 471, a statistical analysis of the data is not mandatory.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: the test item precipitated in the overlay agar in the test tubes and on the incubated agar plates from 1000 up to 5000 μg/plate in both experiments. The undissolved particles of the test item had no influence on the data recording.

RANGE-FINDING/SCREENING STUDIES:
To evaluate the toxicity of the test item a pre-experiment was performed with all strains used. Eight concentrations were tested for toxicity and mutation induction with each 3 plates. The experimental conditions in this pre-experiment were the same as described for the experiment I (plate incorporation test). Toxicity of the test item can be evident as a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn. The pre-experiment is reported as main experiment I, since the criteria evaluable plates (>0 colonies) at five concentrations or more in all strains used are met.
Remarks on result:
other: Test system: all strains/cell types tested

Any other information on results incl. tables

DISCUSSION OF RESULTS

- The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used.

- Toxic effects, evident as a reduction in the number of revertants (below the induction factor of 0.5), were observed at the following concentrations (μg/plate):

Strain

Experiment I

Experiment II

 

without S9 mix

with S9 mix

without S9 mix

with S9 mix

TA 1535

/

2500 - 5000

2500

5000

TA 1537

5000

2500 - 5000

/

5000

TA 98

/

5000

/

5000

TA 100

/

5000

/

5000

TA 102

5000

2500 - 5000

5000

2500 - 5000

/ = no toxic effects evident as a reduction in the number of revertants (below the induction factor of 0.5)

- No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with Disodium titanate at any concentration level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.

 

Summary of results of experiment I:

Metabolic

activation

Test group

Dose level

[µg/plate]

Revertant colony counts (mean ± SD)

TA 1535

TA 1537

TA 98

TA 100

TA 102

 

Without activation

Deionised water

-

16±5

11±1

28±6

139±12

382±24

Untreated

-

14±1

13±2

34±6

146±8

369±34

Disodium titanate

3µg

13±3

11±3

27±7

131±3

363±26

10 µg

15±3

13±2

24±2

148±11

398±9

33 µg

15±1

10±2

30±3

140±5

413±14

100 µg

15±2

12±2

26±5

124±12

403±22

333 µg

16±4

10±2

25±5

131±9

373±13

1000 µg

 11±4P

 09±1P

28±5P

132±4P

 398±29P

2500 µg

12±2P

 6±1P

23±1P

123±18P

238±19P

5000 µg

  11±1PM

   2±2PM

24±3PM

131±4PM

75±10PM

NaN3

10 µg

1935±127

-

-

2012±67

-

4-NOPD

10 µg

-

-

329±26

-

-

4-NOPD

50 µg

-

70±5

-

-

-

MMS

3.0 µL

-

-

-

-

3163±174

 

With activation

Deionised water

-

22±5

14±4

39±10

131±17

611±24

Untreated

-

22±2

13±3

51±4

137±7

559±19

Disodium titanate

3 µg

23±3

17±3

40±5

125±10

568±8

10 µg

22±6

14±3

 41±10

131±5

598±12

33 µg

23±1

15±1

41±3

128±5

565±9

100 µg

20±6

14±1

37±4

138±5

537±23

333 µg

   15±1

15±7

43±13

137±8

530±38

1000 µg

14±1P

14±3P

41±10P

118±13P

421±37PM

2500 µg

8±2PM

 4±1PM

22±6PM

108±4PM

25±4PM

5000 µg

2±2PM

1±1PM

11±1PM

 38±3PM

5±2PM

2-AA

2.5 µg

483±31

437±42

2941±199

3297±56

-

2-AA

10.0 µg

-

-

-

-

3252±169

Summary of results of experiment II:

 

Metabolic

activation

Test group

Dose level

[µg/plate]

Revertant colony counts (mean ± SD)

TA 1535

TA 1537

TA 98

TA 100

TA 102

 

Without activation

Deionised water

-

15±2

25±1

29±1

145±10

409±9

Untreated

-

18±2

24±0

36±8

144±7

398±35

Disodium titanate

3

16±6

28±3

26±3

139±10

385±6

10

17±2

27±3

30±4

147±16

386±6

33

16±4

24±9

30±3

137±4

394±4

100

19±2

26±1

30±2

150±4

370±9

333

14±6

25±3

27±4

134±10

371±3

1000

9±3P

 24±10P

29±1P

141±17P

  360±14P

2500

5±3P

21±7P

25±2P

118±14P

  334±10P

5000

9±2PM

18±4PM

 22±4PM

124±10P

 53±9PM

NaN3

10

1757±92

-

-

1997±58

-

4-NOPD

10

-

-

  305±2

-

-

4-NOPD

50

-

   80±9

-

-

-

MMS

3.0 µL

-

-

-

-

3617±110

 

With activation

Deionised water

-

23±4

24±3

39±2

152±3

603±10

Untreated

-

21±4

27±2

46±1

154±19

517±60

Disodium titanate

3

23±7

22±3

38±3

155±10

598±16

10

23±4

25±4

40±4

156±11

600±14

33

20±2

30±3

41±7

162±7

636±54

100

24±5

29±1

43±5

168±14

588±77

333

20±5

21±8

39±6

149±20

562±65

1000

16±4P

19±4P

38±6P

141±7P

427±20PM

2500

14±4P

13±0P

 31±10P

97±16P

63±9PM

5000

   3±1PM

 1±1PM

16±4PM

66±10PM

6±2PM

2-AA

2.5

 427±28

387±3

2644±148

2542±4

-

2-AA

10.0

-

-

-

-

2491±7

NaN3

 

sodium azide

P

 

Precipitate

 

2-AA

 

2-aminoanthracene

M

Manual count

MMS

 

methyl methane sulfonate

 

 

4-NOPD

4-nitro-o-phenylene-diamine

 

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results: negative

Disodium titanate is considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
Executive summary:

In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.